Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 645Pancreatic Neoplasms 392Carcinoma, Hepatocellular 308Stomach Neoplasms 252Rectal Neoplasms 182Colonic Neoplasms 182Esophageal Neoplasms 171Carcinoma, Non-Small-Cell Lung 169Breast Neoplasms 150Neoplasms 135Neoplasm Metastasis 131Ovarian Neoplasms 123Cholangiocarcinoma 112Lung Neoplasms 108Liver Neoplasms 107Gastrointestinal Neoplasms 98Melanoma 87Biliary Tract Neoplasms 77Prostatic Neoplasms 75Endometrial Neoplasms 74Esophageal Squamous Cell Carcinoma 67Carcinoma, Renal Cell 57Squamous Cell Carcinoma of Head and Neck 54Sarcoma 54Uterine Cervical Neoplasms 51Adenocarcinoma Of Esophagus 47Head and Neck Neoplasms 46Urinary Bladder Neoplasms 42Triple Negative Breast Neoplasms 39Anus Neoplasms 36

Interventions

temsirolimus 1dehydroftorafur 1Vincristine 1Sirolimus 1Razoxane 1Platinum 1Liver Transplantation 1Irinotecan 1Fluorouracil 1Doxorubicin 1Dexrazoxane 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
PRETEXT I Hepatoblastoma × Gastrointestinal × 90 days × Clear all
NCT00980460 2026-05-04

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
236 enrolled 18 charts
Gastrointestinal

PRETEXT I Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡